Saudi Pharmaceutical Industries and Medical Appliances Corporation

SASE:2070 株式レポート

時価総額:ر.س3.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Saudi Pharmaceutical Industries and Medical Appliances 過去の業績

過去 基準チェック /06

Saudi Pharmaceutical Industries and Medical Appliancesは23.2%の年平均成長率で業績を伸ばしているが、Pharmaceuticals業界はgrowingで11%毎年増加している。売上は減少しており、年平均0%の割合である。

主要情報

23.2%

収益成長率

23.2%

EPS成長率

Pharmaceuticals 業界の成長12.4%
収益成長率-0.002%
株主資本利益率-1.6%
ネット・マージン-2.5%
前回の決算情報31 Mar 2024

最近の業績更新

Recent updates

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Mar 21
Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Jun 26
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Mar 14
Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Aug 02
Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

May 19
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

May 12
One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Feb 20
A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 18
Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Mar 30
Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

Feb 23
Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Jan 19
What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Dec 16
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

収支内訳

Saudi Pharmaceutical Industries and Medical Appliances の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SASE:2070 収益、費用、利益 ( )SAR Millions
日付収益収益G+A経費研究開発費
31 Mar 241,597-4061346
31 Dec 231,653-2061641
30 Sep 231,687-5863847
30 Jun 231,662-6264351
31 Mar 231,564-13166247
31 Dec 221,422-15263143
30 Sep 221,425-9458951
30 Jun 221,379-4256341
31 Mar 221,3943854736
31 Dec 211,4603053729
30 Sep 211,4715752714
30 Jun 211,53211751920
31 Mar 211,53411051320
31 Dec 201,55513053220
30 Sep 201,521-1146111
30 Jun 201,491-1536111
31 Mar 201,518-3656577
31 Dec 191,487-43465313
30 Sep 191,743-16358640
30 Jun 191,626-20459440
31 Mar 191,566655139
31 Dec 181,5037454140
30 Sep 181,3136651734
30 Jun 181,3666150037
31 Mar 181,3758545939
31 Dec 171,38613948837
30 Sep 171,31527458936
30 Jun 171,29529660531
31 Mar 171,32928965431
31 Dec 161,25927763331
30 Sep 161,44812456348
30 Jun 161,49914954441
31 Mar 161,59534755933
31 Dec 151,70535756125
30 Sep 151,6044575740
30 Jun 151,5624655700
31 Mar 151,5003255580
31 Dec 141,4703175520
30 Sep 141,4242835470
30 Jun 141,3812795280
31 Mar 141,3512955160
31 Dec 131,3112675020
30 Sep 131,2942644840
30 Jun 131,2992624740

質の高い収益: 2070は現在利益が出ていません。

利益率の向上: 2070は現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 2070は利益を出していないが、過去 5 年間で年間23.2%の割合で損失を削減してきた。

成長の加速: 2070の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: 2070は利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 6.8% ) と比較することは困難です。


株主資本利益率

高いROE: 2070は現在利益が出ていないため、自己資本利益率 ( -1.59% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘